Angel investors & venture capitalists in Massachusetts, United States

research biotechnology life sciences biotechnology: biological products (no diagnostic substances) health care biotechnology research biotech for lupus biotech biotech leadership biotech company clinical research biotech manufacturing neurodegenerative diseases biotech r&d biotech for neurodegenerative diseases mental health biotech patient care biotech clinical research drug development tau pathology biotech innovation biotech biotech mergers biotech therapies neuroscience innovation biotech for sma research and development in the physical engineering and life sciences biotech biotech r&d rare diseases biotech health impact biotech biotech manufacturing biotech acquisitions biotech biotech collaborations biotech biotech mergers b2b biotech collaborations manufacturing biotech pipeline biotech for rare genetic disorders biotech biotech acquisitions biotech market biotech biotech market neurodegeneration patient care biotech biotech hub clinical trial innovation biotech products biotech innovation strategy biotech regulatory approval clinical trials biotech for alzheimer's biotech for kidney disease rare disease treatments neuroscience biotech pipeline management antisense oligonucleotides biotech innovation ecosystem healthcare pharmaceuticals biotech treatments biotech biotech innovation biogen biotech research biotech sustainability biotech corporate responsibility blood-based biomarkers biotech drug development biotech research and development biotech for ms biotech leadership neurotherapeutics biotech for postpartum depression biopharmaceuticals biotech industry services rare genetic disorders biotech biotech pipeline alzheimer's disease amyotrophic lateral sclerosis friedreich ataxia lupus multiple sclerosis postpartum depression spinal muscular atrophy biologics medicines research and development biosimilars health equity patient support programs r&d expertise therapeutic solutions innovative therapies early access programs health disparities cognitive screening autoimmune diseases immunological pathways diversity equity inclusion community health programs safety information enhanced quality of life transformative medicines functional outcomes neuroimmunology medical professionals drug efficacy patient recruitment investigational therapies scientific collaborations creative healthcare solutions personalized medicine genetic variants preventative care support networks health wellness & fitness hospital & health care mechanical or industrial engineering medical research & development

research cystic fibrosis alpha1 antitrypsin deficiency apol1mediated kidney diseases sickle cell disease beta thalassemia duchenne muscular dystrophy type 1 diabetes mellitus pharmaceuticals life sciences biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceuticals innovative medicines gene editing crispr specialty markets transformative therapies rare genetic disorders precision medicine patient care scientific innovation drug development cftr modulators cell therapy pain management healthcare professionals global presence customer satisfaction patient demographics inclusion diversity equity acquisitions research facilities biotechnology chronic diseases fda approvals market leadership competitive landscape therapeutic areas patient advocacy healthcare solutions transformative healthcare crispr therapy genetic disorders clinical trials rare diseases apol1-mediated kidney disease type 1 diabetes transformative medicines research and development patient engagement innovative therapies fda approval drug discovery mrna technology employee giving corporate responsibility environmental sustainability clinical data medical advancements vertex foundation inclusion and diversity healthcare innovations scientific research partner collaborations patient access programs early access medicines transformative treatments regulatory compliance patient support healthcare equity community engagement scientific education stem initiatives pharmaceutical development safety and quality assurance adverse event reporting global outreach disease awareness patients-first approach manufacturing operations biotech collaboration clinical programs real-world evidence b2b services medical health wellness & fitness hospital & health care research & development

research oncology hematology cancer treatment solid tumor targeted therapy biotechnology: pharmaceutical preparations health care biotechnology research immunotherapy cancer therapy personalized cancer medicine regulatory approvals regulatory approval patient enrollment cancer treatment equity pharmaceuticals cancer biomarker cancer drug pipeline checkpoint inhibitors b2b global health impact cdacs biotech pipeline drug development oncology drugs protein degradation regulatory strategy clinical trials global oncology clinical research collaboration next-generation cancer treatments cancer treatment affordability biotech research artificial intelligence drug acceleration bruton's tyrosine kinase inhibitors biopharma innovation cancer treatments antibody drug conjugates biotech manufacturing biotech regulatory strategy pipeline healthcare pharmaceutical and medicine manufacturing immuno-oncology blood cancers solid tumors biotechnology biotech next-generation oncology cancer drug innovation biotech company cancer combination therapy cancer immunotherapy oncology innovation cancer treatment development biotech global expansion oncology clinical trial design biotech innovation services cancer patient advocacy cancer care oncology biomarkers biotech r&d patient access biopharma cancer treatment access clinical research clinical development therapeutic development oncology pipeline cancer research global presence global biotech biopharmaceutical cancer pipeline neoadjuvant therapy global clinical trials innovative medicines adjuvant therapy biosimilar development targeted cancer therapy manufacturing hospital & health care health wellness & fitness medical information technology & services mechanical or industrial engineering

research biotechnology microfluidic automation life sciences dna synthesis microfluidics science hardware electronics dna oligos dna primer dna probe life science pressurevalve system rna synthesis labroutine synthesis microfluidic chip qpcr rtpcr taqman fishprobe rna rnasynthesis dnasynthesizer rnasynthesizer dnamodification